Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • How smart spaces and real-time strategy transformed ASCO® 2025

    August 19, 2025 | Congress, Inizio, oncology 

    - PMLiVE

    Nick Bellomo, Director of Technology and Engagement, Inizio Medical

    ASCO® 2025 wasn’t just about oncology breakthroughs – it was also a showcase for how technology is redefining congress engagement. Supporting dozens of clients with hundreds of deliverables, Inizio had a front-row seat to innovations that are reshaping how healthcare professionals (HCPs) learn and interact.

    Highlights from the floor:

    • LED walls reimagined: Once static displays, LED walls are now interactive storytelling tools. From gesture-responsive MOAs to live trial dashboards, these experiences empowered HCPs to navigate content at their own pace, boosting engagement and driving more meaningful conversations.

    • Real-time in-booth analytics: Inizio piloted offline analytics that delivered live insights without internet dependency. This allowed brands to refine content mid-show, optimize staff alignment, and deliver more targeted education – all during the congress, not weeks later.

    Why it matters:
    These shifts mark a broader transformation: moving from passive storytelling to responsive engagement, and from delayed insights to real-time adaptability. For HCPs, this means richer, more relevant learning. For brands, it means smarter strategies and more impactful outcomes.

    At Inizio, the booth is no longer just a backdrop – it’s a catalyst for strategic engagement and patient-focused progress.

    Read the full article authored by Nick here. Discover more in the on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Research Partnership has been ranked in the Pharma Times Pharma Fast 50

    Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research...

    Women’s health in emerging markets

    Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

    Research Partnership has published a new Living with Lupus (SLE) market report for 2017

    SLE is a progressive and debilitating disease which affects 5 million people worldwide.

    PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

    Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

    Cool heads in a crisis?

    Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

    Biosimilars: Bringing patients into the conversation

    Published in eyeforpharma January 2017 by Mariel Metcalfe

    Access and elimination: the future of DAAs in hepatitis C

    Published in Pharmaphorum January 2017

    EphMRA One Day Meeting

    We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

    Video: Segmentation research

    Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...

    Pharmaceutical Market Research Conference 2017

    We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.